Trial Profile
A retrospective study to evaluate the efficacy and safety of lacosamide as a add-on therapy in children with Lennox-Gastaut syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Lennox-Gastaut syndrome
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2015 New trial record